Epidemiology of Pediatric Inflammatory Bowel Disease

Rabia Khan1, M Ellen Kuenzig2, Eric I Benchimol3

  • 1SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children (SickKids), 555 University Avenue, Toronto, ON M5G 1X8, Canada.

Insights

Pediatric inflammatory bowel disease (IBD) is rising globally. Environmental factors like diet, antibiotics, and pollution may trigger IBD in genetically susceptible children, impacting gut health.

Area of Science:

  • Gastroenterology and Immunology
  • Pediatric Health
  • Environmental Medicine

Background:

  • Inflammatory bowel disease (IBD), encompassing Crohn disease and ulcerative colitis, is a chronic inflammatory condition.
  • IBD is increasingly diagnosed in children and adolescents worldwide.
  • Genetic predisposition combined with environmental factors triggers IBD through a dysregulated mucosal immune response to gut microbiota.

Purpose of the Study:

  • To provide an overview of the epidemiology of pediatric-onset IBD.
  • To explore various environmental risk factors contributing to the development of IBD in children.
  • To synthesize current knowledge on factors influencing pediatric IBD incidence.

Main Methods:

  • Literature review and synthesis of epidemiological data on pediatric IBD.
  • Analysis of environmental exposures and their association with IBD development.
  • Discussion of established and emerging risk factors in pediatric IBD.

Main Results:

  • Global incidence and prevalence of pediatric IBD are increasing.
  • Key environmental factors implicated include the Hygiene Hypothesis, air pollution, reduced exposure to greenspace and bluespace, neonatal factors, antibiotic use, and dietary patterns.
  • These factors interact with host genetics to influence the gut immune system.

Conclusions:

  • Understanding pediatric IBD epidemiology is crucial for public health initiatives.
  • Environmental factors play a significant role in the rising rates of pediatric IBD.
  • Further research into specific environmental triggers and their mechanisms is warranted to inform prevention and treatment strategies.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
291
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
215
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
152
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
313